Glia and alpha-synuclein in neurodegeneration: A complex interaction - Wikidata - awgldk - TriplyDB

Glia and alpha-synuclein in neurodegeneration: A complex interaction

Glia and alpha-synuclein in neurodegeneration: A complex interaction

http://www.wikidata.org/entity/Q26851153

about

Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine The associations between Parkinson's disease and cancer: the plot thickens Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-κB Pathway Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity.Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson's Disease Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy Mutant alpha-synuclein causes age-dependent neuropathology in monkey brain Overexpression of α-synuclein in oligodendrocytes does not increase susceptibility to focal striatal excitotoxicity.Telomere shortening leads to an acceleration of synucleinopathy and impaired microglia response in a genetic mouse model.Aging of perennial cells and organ parts according to the programmed aging paradigm.α-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading.Glia-neuron interactions in neurological diseases: Testing non-cell autonomy in a dish.Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases.Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases.Multiple system atrophy: pathogenic mechanisms and biomarkers.Anle138b Partly Ameliorates Motor Deficits Despite Failure of Neuroprotection in a Model of Advanced Multiple System Atrophy.Brain dopamine neurone 'damage': methamphetamine users vs. Parkinson's disease - a critical assessment of the evidence.The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy.l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?Overlaps between multiple system atrophy and multiple sclerosis: A novel perspective.Striatal astrocytes engulf dopaminergic debris in Parkinson's disease: A study in an animal model.Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.The neuropathology of multiple system atrophy and its therapeutic implications.Multiple system atrophy: experimental models and reality.Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term.Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.Oral Exposure to Paraquat Triggers Earlier Expression of Phosphorylated α-Synuclein in the Enteric Nervous System of A53T Mutant Human α-Synuclein Transgenic Mice.Diversity of astroglial responses across human neurodegenerative disorders and brain aging.Brain monoamine oxidases in human parkinsonian disorders.Beneficial effects of liraglutide (GLP1 analog) in the hippocampal inflammation.Shared and Distinct Patterns of Oligodendroglial Response in α-Synucleinopathies and Tauopathies.New Progress on the Role of Glia in Iron Metabolism and Iron-Induced Degeneration of Dopamine Neurons in Parkinson's Disease.Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy.Glucose Metabolism and AMPK Signaling Regulate Dopaminergic Cell Death Induced by Gene (α-Synuclein)-Environment (Paraquat) Interactions.Limited effects of dysfunctional macroautophagy on the accumulation of extracellularly derived α-synuclein in oligodendroglia: implications for MSA pathogenesis.Microstructural Changes in Patients With Parkinson's Disease Comorbid With REM Sleep Behaviour Disorder and Depressive Symptoms.Rapid dissemination of alpha-synuclein seeds through neural circuits in an in-vivo prion-like seeding experiment Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson's disease animal model Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation Sabotage by the brain’s supporting cells helps fuel neurodegeneration

P2860

Q26768648-7C441C62-FE12-4AF8-89CE-ECD6B7E3CCE1 Q26778641-7F119618-8021-49B8-ACFB-5FBE832AEE56 Q28468427-427F0C24-9856-4E2F-ABF8-A5B9002D3013 Q33735667-9758742F-E530-4E51-A4AA-1D0530D8FB1A Q33749270-ED63046B-64E6-4454-84CD-19FE801EA1EB Q33868678-E4D8036E-B744-4615-A1CF-94C5D9890B64 Q35649563-2D1881CA-2025-46BE-82D7-2DAD0BC1CF92 Q35857994-8E623D93-CD0E-42BF-95B6-95F1C87C6AF8 Q37196069-7F799141-7989-4ABE-84C0-311848AEA138 Q37219569-052CB507-96DB-411C-AE0A-2D92C4CB1E1C Q38671037-4DF418B6-F8CE-4595-923C-B3362A72DF8B Q38700229-B6746B95-65D1-4129-98AE-B4DC6F2C0D8F Q38742951-B378749C-4B2C-4588-85BE-DDF98BD640EC Q38794219-6F2C38E3-77E6-46FD-BC96-9597FCF4F7E3 Q38813304-FFFD0CA1-453B-4BFE-B778-DFE7F12FBDCB Q38886178-9AFBA0CB-CFAE-4C9D-A896-459530E1BD13 Q38926228-6B519DCC-CCA8-4D63-BD7A-8A3C54CB9029 Q38944057-B7AFE10C-D05B-44B5-AA33-DF456569FEAC Q39012371-DA04C253-F5E6-4419-893A-375AAA5F98A6 Q39015117-EB1EDAC3-EBAA-471B-B25D-A477C0EB093E Q42701713-D7238609-D55C-4CEA-8535-ABCA4D0AB0C2 Q43180542-F77DFE77-A203-42E6-BB2C-76E4DC5E8725 Q45940520-D23095F6-AE05-4224-8D33-B17AD05DC686 Q46726761-094A5F5E-4FD6-4CBC-95D8-1EF378751DC0 Q47361450-58843563-ED68-48E0-9AFE-C4B5861E8D0E Q47593688-2B2FFB43-DE79-4AE6-8529-C4CFD5DE852A Q47639323-3FAB7072-6E2B-4F28-87B7-AA46F74A421C Q47929663-DCDE2167-B6A3-420B-B249-3081887375E6 Q48011170-FC0D4B5D-70E9-4D9F-84BA-05B8CBA386BA Q48209483-BD976117-5B69-4C84-A4C8-904F7BF6FA7C Q48494051-E5CAE51A-4132-4CC8-8F65-D9F451DECA6D Q49324255-86ADE8D7-9AFF-475B-9D6C-2C906293CAA0 Q49562668-FEBEFFD5-2325-4AEA-89C9-1F086F2C6EA2 Q51691934-E76A2E33-7FB3-4616-AC96-63965A57A7BA Q55242370-BB2DED82-F716-4C19-BD14-2813661C2D9D Q55664351-37297DD7-6E70-44BA-A3BA-8E8D4B1C0CFC Q58720864-E6B7A44B-9B4C-46F5-BCB9-D5D6AB5811D6 Q58786372-856F0490-73B2-4616-9466-9EC839C3E54F Q58793525-C4E324FA-7FA4-4877-BCA1-B2BCE89DAAC6 Q74441833-A70417D9-9E25-404A-92AB-34CBDC5F6E84

P2860

Glia and alpha-synuclein in neurodegeneration: A complex interaction

http://www.wikidata.org/entity/Q26851153

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Glia and alpha-synuclein in neurodegeneration: A complex interaction

@ast

Glia and alpha-synuclein in neurodegeneration: A complex interaction

@en

Glia and alpha-synuclein in neurodegeneration: A complex interaction

@nl

type

label

Glia and alpha-synuclein in neurodegeneration: A complex interaction

@ast

Glia and alpha-synuclein in neurodegeneration: A complex interaction

@en

Glia and alpha-synuclein in neurodegeneration: A complex interaction

@nl

prefLabel

Glia and alpha-synuclein in neurodegeneration: A complex interaction

@ast

Glia and alpha-synuclein in neurodegeneration: A complex interaction

@en

Glia and alpha-synuclein in neurodegeneration: A complex interaction

@nl

P1433

Q26851153-886A1991-8EFF-4D37-9907-42D020B366F7

P1476

Q26851153-6E4757A2-E38B-4D41-94C7-FFA23FCACF6D

P2093

Q26851153-9198F2AF-2B28-47C6-A66C-351AC9460E19

Q26851153-CF2DC3CE-A900-40B2-94F6-100EB713E0F7

P2860

Q26851153-001C1749-0287-4663-819E-D362071E12C9

Q26851153-026BB2C4-3E92-423D-AB01-C2F60B5888D3

Q26851153-029E2843-6361-47A5-9305-B2DE4B74CD16

Q26851153-04553703-5EA4-4BA2-873F-DD648894E1C4

Q26851153-0540988C-09B8-472B-8226-49AE8624FEFB

Q26851153-0646400B-977C-420B-AC48-9DFA289E03D7

Q26851153-06679605-5B1E-4EAC-9047-0F341CEC801E

Q26851153-068A2864-A923-4C4B-80A4-98F350A72750

Q26851153-07F4F56F-6DEF-4B63-A54F-AFCFE34E1786

Q26851153-09499BFA-9D72-425F-B02B-46E793ED9C2A

P304

Q26851153-51F67889-4833-4687-8D12-35F84199C3C2

P31

Q26851153-044872F7-B2FC-4F6B-A0EF-ADCD2CFB8459

P356

Q26851153-4D1C02B1-F460-4E5A-A9D8-0C3385FD5C08

P407

Q26851153-6FE4B7B1-DB9E-4DE6-83D4-6F731734212D

P478

Q26851153-9EC674B9-8DCA-4055-8119-1869062DF510

P50

Q26851153-64FB0145-9A80-43A8-B85C-3FD4D5AE04B9

Q26851153-DFA4D5EF-1A79-4D1E-9E4D-5FB6B6AAE4E5

P577

Q26851153-6FFBF37A-B13D-4F7F-A8A3-47DA82F2B247

P5875

Q26851153-A0D6DAB3-1921-4086-ADBD-C578B4E8D15A

P698

Q26851153-DE05AF89-7FC0-4F79-B381-B899769E385B

P921

Q26851153-B38F75B4-0CEB-4372-9B39-561383E198F3

Q26851153-DDE0EB0E-7D39-4432-83E7-5E22592D0EAF

P932

Q26851153-A8018973-40BF-47DD-B537-F139D23DA541

P356

J.NBD.2015.03.003

P1433

Neurobiology of Disease

P1476

Glia and alpha-synuclein in neurodegeneration: A complex interaction

@en

P2093

Dominik Brück

http://www.w3.org/2001/XMLSchema#string

Lisa Fellner

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy

The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress

p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin

Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease

α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells.

Genome-wide association study reveals genetic risk underlying Parkinson's disease

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein

p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy

P304

262-274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NBD.2015.03.003

http://www.w3.org/2001/XMLSchema#string

P407

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

Nadia Stefanova

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273398046

http://www.w3.org/2001/XMLSchema#string

P698

25766679

http://www.w3.org/2001/XMLSchema#string

P921

P932

4730552

http://www.w3.org/2001/XMLSchema#string